Otros idiomas Sinopharm Group Co. Ltd.

Acciones

1099

CNE100000FN7

Farmacéuticos

Mercado cerrado - Hong Kong S.E. Otros sitios de cotización 09:08:13 11/02/2026			Variación 5 días	Varia. 1 de enero.
21,12 ^HKD	-1,12 %		0,00 %	+8,64 %

21/01	Se espera que el Banco de China, China Construction Bank, China Mobile, ICBC, Sinopharm, CRRC y BYD se unan, según fuentes	RE
03/12	Shanghai Henlius Biotech renueva su acuerdo de distribución con Sinopharm	CI

Otros idiomas

21/01	China's Bank of China, China Construction Bank, China Mobile, ICBC, Sinopharm, CRRC, BYD expected to join - sources
03/12	Shanghai Henlius Biotech, Inc. Renewal of the Sinopharm Distribution Agreement
28/11	Sinopharm Group Co. Ltd. Announces Board and Committee Resignations
28/11	Sinopharm says Zhao Bingxiang resigns as chairman
26/11	JPMorgan Chase & Co's short position in H-shares of Sinopharm Group decreased to 1.45% on Nov 21 - HKEX
11/11	US Government Shutdown, Earnings Views Roil Asian Stock Markets
06/11	Sinopharm Group Co. Ltd. Announces Resignation of Sun Jinglin as an Executive Director and A Member of the Strategy and Investment Committee of the Board
27/10/25	Sinopharm Group's Nine-Month Profit Rises Despite Revenue Drop
27/10/25	Sinopharm Group posts 9M net profit attributable RMB5.31 billion
21/10/25	China National Medicines' Q3 Profit Jumps 13%
21/10/25	China National Accord Medicines' Q3 Profit Slumps 10%
21/10/25	Sinopharm Group Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
17/09/25	Bristol Myers Squibb Exits China JV
25/08/25	Sinopharm Group Co. Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
25/08/25	Sinopharm : 2025 Interim Results Presentation
25/08/25	Sinopharm Group Books 6% Lower Profit in H1
20/08/25	Sinopharm Group says HY net profit attributable for China National Medicines Corp of RMB948.5 million
12/06/25	Sinopharm Group Co. Ltd. Approves Final Ordinary Cash Dividend for the Year Ended 31 December 2024, Payable No Later Than 12 August 2025
12/06/25	Sinopharm Group Co. Ltd. Approves Board Appointments
10/06/25	Sinopharm Unit to Acquire 21% Stake in Pacific Shuanglin Bio-pharmacy
09/06/25	Sinopharm Group Appoints Hu Ligang As A Vice President
09/06/25	Sinopharm Group Co. Ltd Announces Resignation of Hu Ligang as Non-Executive Director, Effect from 9 June 2025
16/05/25	Sinopharm Group Co. Ltd. Announces Retirement of Mr. Li Dongjiu as Non-Executive Director, Member of the Audit Committee and A Member of the Strategy and Investment Committee, Effective May 16, 2025
28/04/25	Sinopharm's Q1 Profit Jumps
28/04/25	Sinopharm Group Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripciones Comunicados Publs. oficiales Otros idiomas Artículos de MarketScreener Estrategias MarketScreener Ideas de trading

Otros idiomas Sinopharm Group Co. Ltd.

Acciones

1099

CNE100000FN7

Farmacéuticos

Otros idiomas

Filtros